EN
A Decade of Exploration | iGeneTech Achieves Precise Tracing of Origins and Early Detection of Influenza Viruses
How much do you know about influenza viruses?Influenza, abbreviated as flu, is an acute respiratory infectious disease caused by influenza viruses. It is highly contagious and has the characteristics ...
Custom MRD Testing for free, Delivery to Client in Just 5 Days Technical Recommendations in Expert Consensuses
Since 2021, three expert consensuses on solid tumor MRD testing have been published, with increasingly detailed technical recommendations, reflecting deepening understanding of MRD testing in precisio...
Decade of Breakthroughs | iGeneTech AIExome V5, Reshaping the Industry Landscape with Exceptional Uniformity and High-Efficiency Capture Technology
In an era of rapid advancements in precision medicine and genomics, whole exome sequencing has emerged as a pivotal technological tool driving both research and clinical applications. However, the per...
Decade of Partnership | Seven-Fold All-Round Excellence: iGeneTech NGS Library Preparation Kit
Library construction is a critical step in high-throughput sequencing, including next-generation sequencing (NGS, such as Illumina platforms) and third-generation sequencing (e.g., PacBio SMRT, Oxford...
iGeneTech Index product line has been expanded, now offering up to 4,608 different types.
Index (also known as Barcode) plays a critical role in high-throughput sequencing as a unique nucleotide sequence used to distinguish different samples. It is added to the sequencing libraries of DNA ...
Whether the MRD monitoring is effective should be verified by the quantity of test samples and clinical data
The NCCN Clinical Practice Guidelines Update (2025 V1) incorporates important MRD - related information: In the field of B - cell lymphoma, for patients with diffuse large B - cell lymphoma (DLBCL) wh...
The Standardization Administration of China (SAC) has approved and released the national standard Forensic Sciences—Basic Requirements for Quality of Next Generation Sequencing-Based Reagents! iGeneTech jointly participated in its drafting
Recently, the State Administration for Market Regulation (SAMR) (Standardization Administration of China (SAC)) released Announcement No. 17 of 2024 on China National Standards. Among them, GB/T 44322...
Decade of Breakthroughs | iGeneTech Launches Multiple Extraction Kits
Established in 2014, iGeneTech is the first domestic company centered on targeted capture solutions, leveraging three core underlying technology platforms with independent intellectual property rights...
iGeneTech Empowers Precision Detection and Traceability of Monkeypox Virus
Since 2022, the global community has witnessed an unprecedented surge in monkeypox cases, driven by the rapid spread of the highly transmissible Clade IIb variant in non-endemic regions, followed by t...
Decade of Focus | iGeneTech HLA Products Empower High-Precision Typing
Human leukocyte antigen (HLA), the major histocompatibility complex (MHC) in humans, determines cellular histocompatibility and immune response capabilities to different antigens. HLA testing is close...
Company
As an upstream supplier, iGeneTech has focused on gene capture technology research and development since our establishment in 2014. iGeneTech is currently the only company in China that has two sets o...
Help the Global Fight Against Virus! Another New SARS-CoV-2 Clinical Amplicon Sequencing Kit of iGeneTech has Obtained CE Certification
On July 22, 2021, the SARS-CoV-2 Clinical Amplicon Sequencing Kit independently developed by iGeneTech passed the EU IVDD CE certification and obtained the in vitro diagnostic reagent registration lic...
CN